EUROPEAN RADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-10-08 12186135m89(暂无昵称)

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：radiology
经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~

935 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-08-07 手可摘星辰秒来自河南省

记录一下投稿过程
2023.7.14(New Submission)
2023.7.26(Under Review)

195 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-09-27 ms1000001001185102 来自江苏省

投稿命中率:25.0
经验分享：new submission了两个多月，写信问一下火速拒稿

112 0

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-07-17 ms9000001060919133 来自河南省

想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？

205 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-07-08 稀饭苹果

偏重的研究方向：肿瘤CT;临床
经验分享：历经大半年的时间终于Online了，

223 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-06-27 路芸芸来自北京

审稿速度:24.0 | 投稿命中率:50.0
经验分享：22年11月份投稿
23年2月份建议重投
23年3月份重投
23年5月份小修
23年6月27拒稿
我真是觉得离谱……不想接受早点拒稿不行吗？

127 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-11-24 ms5000000596772308 来自广东省

偏重的研究方向：超声成像技术
经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。

559 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-10-14 ms9000001693280849

投稿40天了，还是new submission，我的天啦

792 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-05-15 小李mri 来自内蒙古

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;临床研究
经验分享：2022.12.5 投出
2023.1.21 邀请审稿人
2023.3.25 审稿完成
2023.3.31 大修
2023.4.5 投回
2023.4.18 格式有问题，再次修改完投回
2023.5.6 原则上接收，需要小修
2023.5.14 接收

字数超了约10%左右，貌似在杂志社允许范围之内。
一共找了4个审稿人，小方向是机器学习。
审稿期间催过几次，但是真慢啊= =。

67 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092498, encodeId=41ad209249821, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：radiology 经验分享：严格根据期刊要求写，审稿周期历时一个多月，审稿人温柔且象征性问了俩问题就接收了~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8a52261621, createdName=12186135m89(暂无昵称), createdTime=Sat Oct 08 14:55:38 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151638, encodeId=c9f421516389b, content=记录一下投稿过程 2023.7.14(New Submission) 2023.7.26(Under Review), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db835566403, createdName=手可摘星辰秒, createdTime=Mon Aug 07 16:38:16 CST 2023, time=2023-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2160008, encodeId=c6412160008ab, content=投稿命中率:25.0 经验分享：new submission了两个多月，写信问一下火速拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e5d5548810, createdName=ms1000001001185102, createdTime=Wed Sep 27 10:47:56 CST 2023, time=2023-09-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2148462, encodeId=828321484620f, content=想请问一下，如果投稿后，共同作者在确认邮件中误点了拒绝链接，该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83995718772, createdName=ms9000001060919133, createdTime=Mon Jul 17 15:46:54 CST 2023, time=2023-07-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146934, encodeId=32fa2146934c7, content=偏重的研究方向：肿瘤CT;临床 经验分享：历经大半年的时间终于Online了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230531/cb74c68a34e446559ce76539b1f80812/6a4bfc503d674ccaa1050e381cc12347.jpg, createdBy=9e7d5565490, createdName=稀饭苹果, createdTime=Sat Jul 08 08:08:02 CST 2023, time=2023-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145003, encodeId=ea33214500360, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：22年11月份投稿 23年2月份建议重投 23年3月份重投 23年5月份小修 23年6月27拒稿 我真是觉得离谱……不想接受早点拒稿不行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e335435852, createdName=路芸芸, createdTime=Tue Jun 27 11:28:28 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2102356, encodeId=b999210235625, content=偏重的研究方向：超声成像技术 经验分享：投稿要谨慎，早看到这个论坛就不投这个期刊了，六周了还New submission，太慢了天呐着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7f88369965, createdName=ms5000000596772308, createdTime=Thu Nov 24 09:11:58 CST 2022, time=2022-11-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093769, encodeId=2f1e2093e6994, content=投稿40天了，还是new submission，我的天啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=792, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f288137005, createdName=ms9000001693280849, createdTime=Fri Oct 14 14:00:18 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2133820, encodeId=9c63213382055, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床研究 经验分享：2022.12.5 投出 2023.1.21 邀请审稿人 2023.3.25 审稿完成 2023.3.31 大修 2023.4.5 投回 2023.4.18 格式有问题，再次修改完投回 2023.5.6 原则上接收，需要小修 2023.5.14 接收 字数超了约10%左右，貌似在杂志社允许范围之内。 一共找了4个审稿人，小方向是机器学习。 审稿期间催过几次，但是真慢啊= =。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19ef5516560, createdName=小李mri, createdTime=Mon May 15 04:27:36 CST 2023, time=2023-05-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2101136, encodeId=78e32101136f8, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：PET/CT 经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35174888083, createdName=416386936, createdTime=Thu Nov 17 16:11:48 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-11-17 416386936

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：PET/CT
经验分享：5-11 submit，5-25、6-23修改格式后再投，7.14 一审review complete，8-5 major revision，9-5 resubmit，10.26 review complete，11.16 reject，编辑建议针对问题修改后可以在重投，有没有同仁有相似的经历，并且最后accept？需要鼓励

392 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务